Thromboelastography‐Guided Blood Component Use in Patients With Cirrhosis With Nonvariceal Bleeding: A Randomized Controlled Trial

Thromboelastography (TEG) provides a more comprehensive global coagulation assessment than routine tests (international normalized ratio [INR] and platelet [PLT] count), and its use may avoid unnecessary blood component transfusion in patients with advanced cirrhosis and significant coagulopathy who...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hepatology (Baltimore, Md.) Md.), 2020-01, Vol.71 (1), p.235-246
Hauptverfasser: Kumar, Manoj, Ahmad, Juned, Maiwall, Rakhi, Choudhury, Ashok, Bajpai, Meenu, Mitra, Lalita G., Saluja, Vandana, Mohan Agarwal, Prashant, Bihari, Chhagan, Shasthry, Saggere Muralikrishna, Jindal, Ankur, Bhardwaj, Ankit, Kumar, Guresh, Sarin, Shiv K.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Thromboelastography (TEG) provides a more comprehensive global coagulation assessment than routine tests (international normalized ratio [INR] and platelet [PLT] count), and its use may avoid unnecessary blood component transfusion in patients with advanced cirrhosis and significant coagulopathy who have nonvariceal upper gastrointestinal (GI) bleeding. A total of 96 patients with significant coagulopathy (defined in this study as INR >1.8 and/or PLT count 
ISSN:0270-9139
1527-3350
DOI:10.1002/hep.30794